Dr. David Soleimani-Meigooni completed his neurology residency at Washington University, where he was chief resident for education and quality improvement. He is presently a behavioral neurology fellow and clinical instructor at the University of California - San Francisco Memory and Aging Center. His research focuses on advancing the precision use of PET biomarkers for diagnosis of neurodegenerative diseases. The Alzheimer’s Association Clinician Scientist Fellowship Program is supporting this research.